Lapatinib/Letrozole Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C142860
A chemotherapy regimen consisting of lapatinib and letrozole that is used as a treatment for advanced hormone receptor (HR)-positive, HER-2/neu-positive breast cancer. [ ]
Term info
Label
Lapatinib/Letrozole Regimen
Synonyms
- Lapatinib + Letrozole
- Lapatinib Plus Letrozole
- Lapatinib-Letrozole
- Lapatinib/Letrozole Regimen
- Tykerb/Femara
Subsets
NCIT_C160952, NCIT_C160950, NCIT_C116978, NCIT_C116977
Contributing Source
CTRP
Display Name
Lapatinib/Letrozole Regimen
NCI META CUI
CL448598
PDQ Closed Trial Search ID
350434
PDQ Open Trial Search ID
350434
Preferred Name
Lapatinib/Letrozole Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C142860